These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
For the quarterly period ended June 30, 2012
or
[ ] T RANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ____ _ .
HICKOK INCORPORATED
_____________________________________________________________
(Exact name of registrant as specified in its charter)
|
Ohio |
34-0288470 |
|
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
|
|
|
|
10514 Dupont Avenue, Cleveland, Ohio |
44108 |
|
(Address of principal executive offices) |
(Zip Code) |
|
|
|
|
(Registrant's telephone number, including area code) |
(216) 541-8060 |
Indicate by check
whether
the registrant (1) has filed all reports required to be filed by
Section 13
or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months
(or for such shorter period that the registrant was required to file
such
reports), and (2) has been subject to such filing requirements for the
past
90 days.
Yes
X
No___
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months ( or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]
Indicate by check
mark
whether the registrant is a large accelerated filer, an accelerated
filer,
a non-
accelerated
filer, or a small reporting company.
|
Large accelerated filer [ ]
|
Accelerated filer [
]
|
|
Non-
accelerated
filer
[ ]
|
Small reporting
company
[X]
|
|
|
|
HICKOK
INCORPORATED
CONSOLIDATED INCOME STATEMENTS
(Unaudited
)
|
|
Three months ended
June 30,
|
June 30, |
|
|
|
|
|
|
| Net Sales |
|
|
|
|
| Product Sales |
$1,187,294
|
$1,186,989
|
$3,367,985
|
$3,393,998
|
| Service Sales |
84,509
|
89,555
|
263,857
|
308,085
|
|
|
|
|
|
|
| Total Net Sales |
1,271,803
|
1,276,544
|
3,631,842
|
3,702,083
|
|
|
|
|||
| Costs and Expenses | ||||
| Cost of Product Sold |
739,091
|
732,777
|
2,179,037
|
2,029,511
|
| Cost of Service Sold |
53,523
|
59,868
|
178,223
|
213,330
|
| Product Development |
233,490
|
233,205
|
706,720
|
755,207
|
|
Marketing and
Administrative Expenses |
419,022
|
381,611
|
1,154,298
|
1,370,617
|
| Interest Charges |
223
|
1,039
|
5,784
|
1,039
|
| Other (Income) Expense |
(2,571)
|
(6,007)
|
(13,324)
|
(10,009)
|
|
|
|
|
|
|
| Total Costs and Expenses |
1,442,778
|
1,402,493
|
4,210,738
|
4,359,695
|
|
|
|
|
|
|
| Income (Loss) before Provision for Income Taxes |
(170,975)
|
(125,949)
|
(578,896)
|
(657,612)
|
| Income (Recovery of) Taxes |
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
Net
Income (Loss)
|
$(170,975)
|
$(125,949)
|
$(578,896)
|
$(657,612)
|
|
|
|
|
|
|
| Earnings per Common Share: |
|
|
||
| Net Income (Loss) |
$(.12)
|
$(.10)
|
$(.43)
|
$(.52)
|
|
|
|
|
|
|
| Earnings per Common Share |
|
|
||
| Assuming Dilution: |
|
|
||
| Net Income (Loss) |
$(.12)
|
$(.10)
|
$(.43)
|
$(.52)
|
|
|
|
|
|
|
| Dividends per Common Share |
$ - 0 -
|
$ - 0 -
|
$ - 0 -
|
$ - 0 -
|
|
|
|
|
|
|
See Notes to
Consolidated Financial Statements
HICKOK
INCORPORATED
|
|
2012 (Unaudited) |
2011 (Note) |
2011 (Unaudited) |
| Assets | |||
| Current Assets | |||
| Cash and Cash Equivalents |
$591,857
|
$274,530
|
$112,269
|
| Trade Accounts Receivable - Net |
465,240
|
722,731
|
660,804
|
|
Notes Receivable - Current
|
2,400
|
2,400
|
-
|
| Inventories |
1,754,574
|
1,963,943
|
2,123,122
|
| Prepaid Expenses |
39,350
|
53,267
|
62,714
|
|
|
|
|
|
|
|
2,853,421
|
3,016,871
|
2,958,909
|
|
|
|
|
|
| Property, Plant and Equipment | |||
| Land |
233,479
|
233,479
|
233,479
|
| Buildings |
1,429,718
|
1,429,718
|
1,429,718
|
| Machinery and Equipment |
2,349,901
|
2,336,995
|
2,336,995
|
|
|
|
|
|
|
4,013,098
|
4,000,192
|
4,000,192
|
|
| Less: Allowance for Depreciation |
3,684,504
|
3,613,913
|
3,587,483
|
|
|
|
|
|
|
|
328,594
|
386,279
|
412,709
|
|
|
|
|
|
| Other Assets | |||
| Notes Receivable - Long-term |
33,100
|
35,700
|
38,500
|
|
Deposits
|
1,750
|
1,750
|
1,750
|
|
|
|
|
|
|
|
34,850
|
37,450
|
40,250
|
|
|
|
|
|
|
|
$3,216,865
|
$3,440,600
|
$3,411,868
|
|
|
|
|
Note: Amounts derived from audited financial statements previously filed with the Securities and Exchange Commission.
See Notes to Consolidated Financial Statements
|
|
(Unaudited) |
____ 2011 ___ (Note) |
2011 (Unaudited) |
||
|
Liabilities and Stockholders' Equity
|
|||||
| Current Liabilities | |||||
|
Short-term Financing
|
$-
|
$-
|
$185,000
|
||
|
Convertible Notes Payable
|
442,032
|
-
|
-
|
||
| Trade Accounts Payable |
134,293
|
173,848
|
197,447
|
||
| Accrued Payroll & Related Expenses |
108,544
|
142,949
|
151,050
|
||
| Accrued Expenses |
211,259
|
205,208
|
187,682
|
||
| Accrued Taxes Other Than Income |
34,074
|
47,786
|
57,822
|
||
| Accrued Income Taxes |
-
|
-
|
-
|
||
|
|
|
|
|
||
|
|
930,202
|
569,791
|
779,001
|
||
|
|
|
|
|||
|
|
|
|
|
||
|
Long-Term Financing
|
-
|
250,000
|
-
|
||
|
|
|
||||
| Stockholders' Equity | |||||
| Class A, $1.00 par value; authorized |
919,412
|
793,229
|
793,229
|
||
|
|
3,750,000 shares; 919,412 shares outstanding (793,229 shares outstanding at September 30, 2011 and June 30, 2011) excluding 15,795 shares in treasury | ||||
| Class B, $1.00 par value; authorized |
474,866
|
454,866
|
454,866
|
||
|
|
1,000,000
shares; 474,866 shares outstanding (454,866 shares outstanding at
September 30, 2011 and June 30, 2011) excluding 667 shares in treasury
(20,667 shares in treasury at September 30, 2011 and June 30, 2011)
|
||||
| Contributed Capital |
1,299,543
|
1,200,976
|
1,198,111
|
||
| Retained Earnings |
(407,158)
|
171,738
|
186,661
|
||
|
|
|
|
|||
|
|
2,286,663
|
2,620,809
|
2,632,867
|
||
|
|
|
|
|||
|
Stockholders' Equity |
$3,216,865
|
$3,440,600
|
$3,411,868
|
||
|
|
|
|
|||
|
|
2012 | 2011 |
|
|
||
| Cash Flows from Operating Activities: | ||
| Cash received from customers |
$3,889,333
|
$3,391,665
|
| Cash paid to suppliers and employees |
(3,975,789)
|
(4,194,386)
|
| Interest paid |
(6,641)
|
(685)
|
| Interest received |
850
|
528
|
| Income taxes (paid) refunded |
-
|
-
|
|
|
|
|
| Net Cash Provided By (Used In) Operating Activities |
(92,247)
|
(802,878)
|
| Cash Flows from Investing Activities: | ||
| Capital expenditures |
(30,761)
|
-
|
|
Payments received (advances) on notes receivable
|
2,600
|
(38,500)
|
|
Proceeds on sale of assets
|
9,500
|
-
|
|
|
|
|
| Net Cash Provided By (Used In) Investing Activities |
(18,661)
|
(38,500)
|
| Cash Flows from Financing Activities: | ||
|
Convertible Notes issue costs
|
(34,235)
|
-
|
|
Decrease in long-term financing
|
(250,000)
|
-
|
|
Increase in short-term financing
|
-
|
185,000
|
|
Increase in Convertible Notes Payable
|
675,470
|
-
|
|
Sale of Class B shares from treasury
|
37,000
|
-
|
|
|
|
|
| Net Cash Provided By (Used In) Financing Activities |
428,235
|
185,000
|
|
|
|
|
| Net increase (decrease) in cash and cash equivalents |
317,327
|
(656,378)
|
| Cash and cash equivalents at beginning of year |
274,530
|
768,647
|
|
|
|
|
| Cash and cash equivalents at end of third quarter |
$591,857
|
$112,269
|
|
|
|
|
| See Notes to Consolidated Financial Statements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation
of Net Income (Loss) to Net
Cash Provided By (Used In) Operating Activities: |
|
|
|
|
||
| Net Income (Loss) |
$(578,896)
|
$(657,612)
|
|
Adjustments
to reconcile Net Income (Loss)
to net cash provided by operating activities: |
||
| Depreciation |
82,494
|
82,494
|
|
Share-based compensation expense
|
8,547
|
9,750
|
|
Gain on disposal of assets
|
(3,548)
|
-
|
| Changes in assets and liabilities: | ||
| Decrease (Increase) in trade accounts receivable |
257,491
|
(310,418)
|
| Decrease (Increase) in inventories |
209,369
|
(150)
|
| Decrease (Increase) in prepaid expenses |
13,917
|
7,709
|
| Increase (Decrease) in accounts payable |
(39,555)
|
14,411
|
|
Increase (Decrease) in accrued payroll and
related expenses |
(34,405)
|
1,249
|
|
Increase (Decrease) in accrued expenses and
accrued taxes other than income |
(7,661)
|
49,689
|
|
|
|
|
| Total Adjustments |
486,649
|
(145,266)
|
|
|
|
|
| Net Cash Provided By (Used In) Operating Activities |
$(92,247)
|
$(802,878)
|
|
|
|
|
HICKOK
INCORPORATED
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
JUNE 30, 2012
1.
Basis of
Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended June 30, 2012 are not necessarily indicative of the results that may be expected for the year ended September 30, 2012. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the year ended September 30, 2011.
2. Inventories
Inventories are
valued at
the lower of cost or market and consist of the following:
|
|
|
|
|
| Components |
$968,712
|
$1,145,278
|
$1,298,682
|
| Work-in-Process |
537,914
|
515,885
|
517,717
|
| Finished Product |
247,948
|
302,780
|
306,723
|
|
|
|
|
|
|
|
$1,754,574
|
$1,963,943
|
$2,123,122
|
|
|
|
|
|
The above amounts
are net of reserve for obsolete inventory in the amount of
$
845,415
,
$714,000 and $524,476 for
the periods ended June 30, 2012, September 30, 2011 and June 30, 2011
respectively.
3.
Notes Receivable
The Company has
notes receivable with a current and former employee at an
interest rate of three percent per annum. The Company does not
anticipate repayment within the next twelve months.
4.
Convertible Notes Payable
On December
30,
2011, Hickok Incorporated entered into a Convertible
Loan Agreement with Roundball, LLC and the Aplin Family Trust. Under
the Convertible Loan Agreement, the Company issued a convertible note
to Roundball in the amount of $466,879.87 and a convertible note to the
Aplin Family Trust in the amount of $208,591.20. In
addition, Roundball, LLC shall have the right to cause the Company to
borrow up to an additional $466,879.88 from Roundball, LLC. The notes
are
unsecured, bear interest at a rate of 0.20% per annum and will mature
on
December 30, 2012.
The notes may be converted by the Investors at any time into Class A
Common Shares of the Company, at a conversion price of $1.85 per share,
although up to no more than 504,735 Conversion Shares for Roundball and
no more than 112,752 Conversion Shares for the Aplin Family Trust. The
Company has the option to convert the notes at
the expiration date, if the investors
have not during the course of the agreement. On
December 30, 2011, Roundball converted $233,438.55 into Class A Common
Shares
of the Company.
In
addition, the Company sold 20,000 Class B Common Shares currently held
in
treasury to Roundball at a price of $1.85 per share per a subscription
agreement between the Company and Roundball dated December 30, 2011.
5.
Long-term
Financing
The
Company has a
credit
agreement of $250,000 with one of its major shareholders who is also an
employee of the Company. The agreement
was to expire in April 2012 but was modified on January 9, 2012 to
extend the maturity
date to April
2013. Effective October 30, 2012
for the remainder of the agreement, the lender may terminate the
agreement with 45 days written notice, but it is at the discretion of
the Company to deny the termination notice until April 2013 if it will
have a negative effect on the solvency of the Company.
The agreement provides for a
revolving credit
facility of
$250,000 with interest generally equal to three percent per annum plus
prime and is unsecured. In addition, the agreement generally allows for
borrowing based on an amount equal to eighty percent
of eligible accounts receivables or $250,000.
The Company repaid
the outstanding balance of $250,000 on the
Revolving Credit Agreement with Robert L. Bauman on February 1, 2012.
The
Company had no outstanding
borrowings under this loan facility at June 30, 2012.
Under the Employee Plans there are no options currently available for grant and there are no options outstanding at June 30, 2012.
Under the Company's Key Employees
Stock Option Plans (collectively the "Employee Plans"), incentive stock
options, in general, are exercisable for up to ten years, at an
exercise price of
not less than the market price on the date the option is granted.
Non-qualified stock options may be granted at such exercise price and
such other terms and
conditions as the Compensation Committee of the Board of Directors may
determine.
No options may be granted at a price less than $2.925.
Options for
26,850
Class A shares were outstanding
at September 30, 2011 and 41,500 shares
at June
30, 2011 at prices ranging from $3.125 to $5.00 per share.
Options for 26,850 shares at
$3.55 per share expired during the three month
period
ended March 31, 2012.
Options
for 800 shares at a price of $3.55 per share were canceled during the
three month period ended June 30, 2011. Options for 13,850 shares at
prices
ranging from $3.125 to $3.55 per share expired during the three month
period
ended December 31, 2010.
No other options were granted,
exercised, canceled or expired during the three or nine month periods
presented
under the Employee Plans.
The Company's Outside Directors Stock Option Plans (collectively the "Directors Plans"), provide for the automatic grant of options to purchase up to 38,000 shares of Class A Common Stock to members of the Board of Directors who are not employees of the Company, at the fair market value on the date of grant. Options for 42,000 Class A shares were outstanding at June 30, 2012 (38,000 shares at September 30, 2011 and 38,000 shares at June 30, 2011) at prices ranging from $2.925 to $11.00 per share. Options for 8,000 shares at prices ranging from $2.925 to $11.00 were canceled during the three month period ended June 30, 2011. Options for 7,000 and 5,000 shares were granted under the Directors Plans during each of the three month periods ended March 31, 2012 and March 31, 2011, at a price of $2.925 per share. In addition, options for 3,000 shares expired during the three month periods ended March 31, 2012 and March 31, 2011, at $3.55 and $4.25 per share respectively. All outstanding options under the Directors Plans become fully exercisable on March 8, 2015.
The following is a summary of the range of exercise prices for stock options outstanding and exercisable under the Employee Plans and the Directors Plans at June 30, 2012:
|
Employee Plans
|
Outstanding Stock Options Exercisable |
|
|
| Range of exercise prices: | |||
|
$-
|
-
|
$-
|
-
|
|
|
|
|
|
|
|
-
|
$-
|
|
|
|
|
|
|
|
Directors Plans
|
|
|
Weighted Average Remaining
Life
|
Number of Stock
Options
Exercisable
|
Weighted Average
Share
Price
|
| Range of exercise prices: |
|
|
|||
| $2.925 - 5.25 |
23,000
|
$3.43
|
6.8
|
12,667
|
$3.84
|
| $6.00 - 7.25 |
11,000
|
$6.46
|
4.8
|
9,333
|
$6.55
|
| $10.50 -11.00 |
8,000
|
$10.75
|
5.3
|
8,000
|
$10.75
|
|
|
|
|
|||
|
42,000
|
$5.62
|
|
30,000
|
$6.52
|
|
|
|
|
|
|
|
|
The Company accounts for Share-Based Payments under the modified prospective method for its stock options for both employees and non-employee Directors. Compensation cost for fixed based awards are measured at the grant date, and the Company uses the Black-Scholes option pricing model to determine the fair value estimates for recognizing the cost of employee and director services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. Employee stock options are immediately exercisable while Director's stock options are exercisable over a three year period. The fair value of stock option grants to Directors is amortized over the three year vesting period. During the three and the nine month periods ended June 30, 2012 and June 30, 2011 respectively $2,841 and $8,547 ; $2,865 and $9,750 was expensed as share-based compensation. The following weighted-average assumptions were used in the option pricing model for the three and nine month periods ended June 30, 2012 and 2011 respectively: a risk free interest rate of 5.5% and 5.5%; an expected life of 10 and 10 years; an expected dividend yield of 0.0% and 0.0%; and a volatility factor of .87 and .75.
7. Recently Issued Accounting Pronouncements
The Company did not incur any material impact to its financial condition or results of operations due to the adoption of any new accounting standards during the periods reported.|
|
June 30, |
June 30, |
|
|
|
|
|
|
| Basic Income (Loss) per Share | ||||
|
Income
(Loss) available
to common stockholders |
$(170,975)
|
$(125,949)
|
$(578,896)
|
$(657,612)
|
|
|
|
|||
| Shares denominator |
1,394,278
|
1,248,095
|
1,346,261
|
1,248,095
|
|
|
|
|||
| Per share amount |
$(.12)
|
$(.10)
|
$(.43)
|
$(.52)
|
|
|
|
|
|
|
| Effect of Dilutive Securities |
|
|
||
| Average shares outstanding |
1,394,278
|
1,248,095
|
1,346,261
|
1,248,095
|
| Stock options |
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
1,394,278
|
1,248,095
|
1,346,261
|
1,248,095
|
|
|
|
|
|||
| Diluted Income (Loss) per Share |
|
|
||
|
Income
(Loss) available
to common stockholders |
$(170,975)
|
$(125,949)
|
$(578,896)
|
$(657,612)
|
|
|
|
|||
| Per share amount |
$(.12)
|
$(.10)
|
$(.43)
|
$(.52)
|
|
|
|
|
|
|
Options to purchase 42,000 shares of common stock during the third quarter and the first nine months of fiscal 2012 at prices ranging from $2.925 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's effect was antidilutive or the exercise price was greater than the average market price of the common share.
In
addition, conversion rights to purchase 491,304 shares of common stock
at a price of $1.85 per share were
not included in the computation of diluted
earnings
per share because the conversion rights of the Convertible Promissory
Notes effect was antidilutive.
During the third quarter and the first nine month period of fiscal 2011, options to purchase 64,850 shares of common stock, at prices ranging from $2.925 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's effect was antidilutive or the exercise price was greater than the average market price of the common shares.
9. Segment and Related InformationThe Company's three business units have a common management team and infrastructure that offer different products and services. The business units have been aggregated into two reportable segments: 1.) indicators and gauges and 2.) automotive related diagnostic tools and equipment.
Indicators and
Gauges
This segment consists
of products manufactured and sold primarily to companies in the
aircraft and locomotive industry. Within the aircraft market, the
primary customers are those companies that manufacture or service
business, military and pleasure aircraft. Within the locomotive market,
indicators and gauges are sold to both original equipment manufacturers
and to operators
of railroad equipment.
Automotive
Diagnostic Tools and Equipment
This segment consists primarily
of products
designed and manufactured to support the testing or servicing of
automotive
systems using electronic means to measure vehicle parameters. These
products
are sold to OEM's and to the aftermarket using several brand names and
a
variety of distribution methods. Included in this segment are products
used
for state required testing of vehicle emissions.
Information by industry
segment is set forth below:
|
|
Three Months Ended
June 30,
|
June 30, |
|
|
|
|
|
|
| Net Revenue | ||||
| Indicators and Gauges |
$537,903
|
$372,606
|
$1,268,278
|
$907,378
|
|
Automotive
Diagnostic
Tools and Equipment |
733,900
|
903,938
|
2,363,564
|
2,794,705
|
|
|
|
|
|
|
|
$1,271,803
|
$1,276,544
|
$3,631,842
|
$3,702,083
|
|
|
|
|
|
|
|
| Income (Loss) before provision for Income Taxes |
|
|
||
| Indicators and Gauges |
$115,290
|
$79,907
|
$216,880
|
$69,444
|
|
Automotive
Diagnostic
Tools and Equipment |
(53,096)
|
5,434
|
(114,052)
|
53,321
|
|
General Corporate Expenses
|
(233,169)
|
(211,290)
|
(681,724)
|
(780,377) |
|
|
|
|
|
|
|
$(170,975)
|
$(125,949)
|
$(578,896)
|
$(657,612)
|
|
|
|
|
|
|
|
| Asset Information |
|
|
||
| Indicators and Gauges |
|
$772,433
|
$728,078
|
|
|
Automotive
Diagnostic
Tools and Equipment |
|
1,444,989
|
2,050,784
|
|
|
Corporate
|
|
|
999,443
|
633,006 |
|
|
|
|
||
|
|
$3,216,865
|
$3,411,868
|
||
|
|
|
|
||
| Geographical Information |
|
|
||
|
Included
in the
consolidated
financial
statements
are
the
following
amounts related
to
geographical
locations:
|
||||
| Revenue: |
|
|
||
| United States |
$1,255,112
|
$1,202,466
|
$3,511,387
|
$3,510,973
|
| Australia |
-
|
-
|
35,609
|
26,945
|
| Canada |
8,799
|
41,794
|
22,551
|
108,974
|
|
England
|
-
|
28,924
|
-
|
28,924
|
|
Mexico
|
3,360
|
3,360
|
23,520
|
20,160
|
|
Taiwan
|
1,270
|
-
|
34,935
|
-
|
| Other foreign countries |
3,262
|
-
|
3,840
|
6,107
|
|
|
|
|
|
|
|
$1,271,803
|
$1,276,544
|
$3,631,842
|
$3,702,083
|
|
|
|
|
|
|
|
All export sales to
Australia, Canada, England,
Mexico, Taiwan and other foreign countries are
made in United States of America Dollars.
10.
Commitments and
Contingencies
Legal
Matters
The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market. Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of this matter will have on the company's results of operations, financial position or cash flows.
The Company is a named defendant along with numerous other companies in a suit in the State of New York regarding asbestos harm to the plaintiff. The Company has been informed by the plaintiff's attorney that we will be dismissed from the suit.
The Company is a named defendant along with numerous other companies in a suit in the State of Michigan regarding asbestos harm to the plaintiff. The Company has engaged a Michigan attorney to provide representation. The Company believes the suit is without merit and expects it will be able to obtain a dismissal for similar reasons a dismissal is imminent in the New York action.
11. Subsequent EventsThe Company has evaluated subsequent events through August 3, 2012 which is the date the financial statements were available to be issued, and has determined there were no subsequent events to recognize or disclose in these financial statements.
12. Business Condition and Management Plan
Results of
Operations, Third Quarter (April 1, 2012 through June 30, 2012)
Fiscal 2012 Compared
to Third Quarter Fiscal 2011
-------------------------------------------------------------------------------------
Reportable Segment Information
The Company has
determined that it has two reportable segments: 1) indicators and
gauges and 2) automotive related diagnostic tools and equipment. The
indicators and gauges segment consists of products manufactured and
sold primarily to companies in the aircraft
and locomotive industry. Within the aircraft market, the primary
customers
are those companies that manufacture or service business, military and
pleasure
aircraft. Within the locomotive market, indicators and gauges are sold
to
original equipment manufacturers, servicers of locomotives and
operators
of railroad equipment. Revenue in this segment was $537,903 and
$372,606
for the third quarter of fiscal 2012 and fiscal 2011, respectively, and
$1,268,278
and $907,378 for the first nine months of fiscal 2012 and fiscal
2011, respectively.
The increased sales volume in the
current year was primarily due to increased orders for military
programs.
The automotive diagnostic tools and equipment segment consists primarily of products designed and manufactured to support the testing or servicing of automotive systems using electronic means to measure vehicle parameters. These products are sold to OEM's and to the aftermarket using several brand names and a variety of distribution methods. Included in this segment are products used for state required testing of vehicle emissions. Revenue in this segment was $733,900 and $903,938 for the third quarter of fiscal 2012 and fiscal 2011, respectively, and $2,363,564 and $2,794,705 for the first nine months of fiscal 2012 and fiscal 2011, respectively. The reduced sales volume was due primarily to reduced orders for automotive diagnostic testing equipment for the aftermarket and emissions related products.
Results of Operations
Product sales for the quarter ended June 30, 2012 were $1,187,294 versus $1,186,989 for the quarter ended June 30, 2011. Sales of indicator products increase d during the current quarter by approximately $176,000 and was volume related and was offset by decreased sales of automotive diagnostic products of approximately $176,000. Within automotive diagnostic products sales of emission products increased by $21,000 and diagnostic products to OEM's and the aftermarket decreased by approximately $131,000 and $66,000 respectively and were volume related. Management continues to be concerned about the current economic conditions in the markets the Company serves . Although the current economic uncertainties make forecasting difficult, product sales are expected to increase slightly during the f ourth quarter of the fiscal year.
S ervice sales for the quarter ended June 30, 2012 were $84,509 versus $89,555 for the quarter ended June 30, 2011. The decrease was volume related and due primarily to a lower sales volume for chargeable repairs. The current level of service sales related to product repair sales is expected to continue in the fourth quarter of the fiscal year.
Cost of product sold in the third quarter of fiscal 2012 was $739,091 ( 62.3 % of product sales) as compared to $732,777 (61.7% of product sales) in the third quarter of 2011. The dollar and percentage increase in the cost of product sold was due primarily to a change in product mix. Management's strategy of developing lower priced higher volume aftermarket products was developed in 2010 in response to a recognition that this was likely to occur due to economic and market conditions. The current cost of product sold percentage is expected to decrease slightly during the fourth quarter of the fiscal year due to an anticipated change in product mix.
Cost of service sold for the quarter ended June 30, 2012 was $53,523 ( 63.3 % of service sales) as compared to $59,868 (66.9% of service sales) in the quarter ended June 30, 2011. The dollar decrease was due primarily to the lower sales volume in the current quarter. T he current cost of services sold percentage is anticipated to continue in the fourth quarter of the fiscal year.
Product development expenses were $233,490 in the third quarter of fiscal 2012 (19.7% of product sales) as compared to $233,205 (19.6% of product sales) in the third quarter of fiscal 2011. During the current quarter there was an increase in labor costs and a decrease in research and experimental material of approximately $4,000 and $6,000 respectively. The current level of product development expenses is expected to increase slightly in the fourth quarter of the fiscal year due to a plan to add a temporary resource and small wage increases effective in February 2012 for existing employees. Management believes the existing and planned resources will be sufficient to continue to develop identified new products for both OEM and Aftermarket customers.Marketing and administrative expenses were $419,022 (32.9% of total sales) in the third quarter of fiscal 2012 versus $381,611 (29.9% of total sales) for the same period a year ago. The dollar increase in expenses for the current fiscal quarter was due to the addition of a marketing resource, additional promotion and a small wage increase for existing employees effective in February and March 2012. Marketing expenses were approximately $183,000 in the third quarter of fiscal 2012 versus $165,000 for the same period a year ago. Within marketing expenses, labor costs, outside consulting, commissions, royalties, promotion and travel expenses increased by approximately $18,000, $3,000, $2,000, $2,000, $2,000 and $1,000 respectively. These increases were offset in part by a decrease in advertising expense and credit and collection expense of approximately $8,000 and $1,000 respectively. Administrative expenses were approximately $236,000 in the third quarter of fiscal 2012 versus $216,000 for the same period a year ago. Within administrative expenses, professional fees and labor costs increased approximately $11,000 and $3,000 respectively. The current level of marketing and administrative expenses is expected to continue during the fourth quarter .
Interest expense was $223 in the third quarter of fiscal 2012 which compares with $1,039 in the third quarter of fiscal 2010. Interest expense for the current quarter was due to interest on the convertible promissory notes payable. Interest expense for the prior year third quarter was due primarily to borrowings on the Company's available credit facility and interest paid on vendor accounts. The current level of interest expense is expected to continue for the fourth quarter of the fiscal year.
Other income was
$2,571 in the third quarter of fiscal 2012 which compares with $6,007
in the
third
quarter of fiscal 2011.
Other income
consists primarily of
the proceeds
from the sale of scrap metal
shavings, purchase discounts and
interest income
on cash and
cash equivalents invested. The decrease is due primarily to a lower
level of scrap metal sales during the current quarter of approximately
$3,100.
Income taxes in the third quarter of fiscal 2012 and 2011 was $-0-. In the third quarter of fiscal 2012 and 2011 a recovery of income taxes was calculated at an effective tax rate of 37% offset by an increase in the valuation allowance netting to $0.
The net loss in the third quarter of fiscal 2012 was $170,975 which compares with a net loss of $125,949 in fiscal 2011. The net loss increase for the current quarter was the result of a lower sales volume, product mix and increased marketing and administrative expenses.
Unshipped customer orders as of June 30, 2012 were
$574,000 versus
$600,000 at June 30, 2011.
The
decrease
was due primarily to decreased orders in automotive diagnostic products
of $69,000, specifically,
$158,000 for emissions products, $49,000 for aftermarket products
offset in part by an increase of $138,000 for OEM products. In
addition, indicators
and gauges increased
by
approximately $43,000
. The
Company estimates that approximately 84% of the current
backlog will be shipped in the last quarter of fiscal 2012.
Resu
lts of Operations, Nine
Months Ended June 30, 2012
Compared to Nine
Months Ended June 30, 2011
Product sales for the nine months ended June 30, 2012 were $3,367,985 versus $3,393,998 for the same period in fiscal 2011. The decrease in product sales during the first nine months of the current fiscal year of approximately $26,000 was volume related due to decreased sales of automotive diagnostic products. Sales of indicator products increase d during the first nine months of the current fiscal year by approximately $380,000 and was volume related and was offset by decreased sales of automotive diagnostic products of approximately $406,000. Within automotive diagnostic products sales of emission products decreased by $199,000 and diagnostic products to OEM's and the aftermarket decreased by approximately $110,000 and $97,000 respectively and were volume related. Management anticipates product sales for the f ourth quarter of the fiscal year to increase slightly.
Service sales for the nine months ended June 30, 2012 were $263,857 compared with $308,085 for the same period in fiscal 2011. The decrease was volume related and due primarily to a lower sales volume for chargeable repairs. The current level of service sales related to product repair sales is expected to continue in the last three months of the fiscal year.
Cost of product sold was $2,179,037 (64.7% of product sales) compared with $2,029,511 (59.8% of product sales) for the nine months ended June 30, 2011. The percentage increase in the cost of product sold was due primarily to a lower sales volume, lower plant utilization and a change in product mix. Management's strategy of developing lower priced higher volume aftermarket products was developed in 2010 in response to a recognition that this was likely to occur due to economic and market conditions. The current cost of product sold percentage is expected to decrease slightly during the fourth quarter of the fiscal year due to an anticipated change in product mix.
Cost of service sold was $178,223 (67.5% of service sales) compared with $213,330 (69.2% of service sales) for the nine months ended June 30, 2011. The dollar and percentage increase was due primarily to the lower sales volume. T he cost of services sold percentage is expected to continue in the fourth quarter of the fiscal year.
Product development expenses were $706,720 (21.0% of product sales) compared to $755,207 (22.3% of product sales) for the nine months ended June 30, 2011. The percentage and dollar decrease was due primarily to lower engineering expenses during the first nine months of the fiscal year. During the current nine month period labor costs and research and experimental material expenses declined by approximately $41,000 and $9,000 respectively. The current level of product development expenditures is expected to increase slightly for the fourth quarter of the fiscal year due to a plan to add a temporary resource and the small wage increases for existing employees effective February 2012. Management believes the existing and planned resources will be sufficient to continue to develop identified new products for both OEM and Aftermarket customers.
Marketing and administrative expenses were $1,154,298 for the nine months ended June 30, 2012 (31.8% of total sales) versus $1,370,617 (37.0% of total sales) for the nine months ended June 30, 2011. The percentage and dollar decrease during the first nine months of the current fiscal year was due primarily to the cost reductions implemented in fiscal 2011. Marketing expenses were approximately $465,000 during the first nine months of the current fiscal year versus $581,000 for the same period a year ago. Within marketing expenses, decreases were primarily in labor costs, travel expenses, advertising expense, royalties, credit and collection expense, commissions and industry association dues of approximately $41,000, $26,000, $16,000, $12,000, $9,000, $3,000 and $3,000 respectively. These decreases were offset in part by an increase in outside consulting expense of approximately $3,000. Administrative expenses were approximately $689,000 during the first nine months of the current fiscal year versus $789,000 for the same period a year ago. The dollar decrease during the first nine months of the current fiscal year was due primarily to decreases in labor costs, directors fees and professional fees of approximately $74,000, $20,000 and $5,000 respectively. The current level of marketing and administrative expenses are expected to increase slightly for the remainder of the fiscal year due to the addition of a marketing resource, additional promotion and the small wage increase for existing employees. These increases became effective in February and March of the current fiscal year.
Interest expense was $5,784 for the nine months ended June 30, 2012, and $1,039 for the same period in 2011. The increase during the current nine months was due primarily to borrowings on the Company's available credit facility. Effective April 2011 the Company obtained a limited unsecured line of credit. Interest expense is expected to continue at the third quarter level during the fourth quarter of the fiscal year due to no anticipated borrowing requirements.
Other income of $13,324 compares
with
other income of $10,009 in the same period last year.
Other income consists
primarily
of the
proceeds
from
the sale of scrap metal shavings,
purchase discounts
and interest income on cash and cash equivalents invested. The increase
is due primarily to
the gain on the
sale of a company vehicle of approximately
$3,500 during the current period.
The current level of other income is expected to decrease for the
remainder of fiscal 2012.
Income taxes during the first nine months of fiscal 2012 were $0 which compares with income taxes of $0 in the first nine months of fiscal 2011. In fiscal 2012 and 2011 a recovery of income taxes was calculated at an effective tax rate of 37% offset by an increase in the valuation allowance netting to $0.
The net loss for the nine months ended June 30, 2012 was $578,896 which compares with a net loss of $657,612 for the nine months ended June 30, 2011. The net loss for the first nine months of fiscal 2012 was primarily the result of lower margins due to product mix, pricing pressure, a lower sales volume and that the 2010 management strategic plan has not had sufficient time to be fully effective offset in part by the cost reduction measures.Liquidity and Capital Resources
Total current assets were
$2,853,421, $3,016,871 and $2,958,909 at June 30, 2012, September 30,
2011 and June 30, 2011, respectively.
The
decrease of approximately $105,000 from June to June is due primarily
to
a decrease in
accounts
receivable, inventory
and prepaid expenses of approximately
$196,000, $369,000 and $23,000
respectively,
offset in part by
an increase in
cash
and cash
equivalents
of
approximately
$480,000.
The
increase in
cash
and cash equivalents was
due primarily to the issuance of convertible promissory notes in
December 2011.
Accounts
receivable decreased due primarily to a lower sales volume during the
current
quarter.
The decrease in
inventory
was
due primarily to a higher obsolescence reserve level during the period.
The decrease from September
2011 to June
2012
of approximately $163,000 is due primarily to the decrease in
accounts receivable,
inventory
and prepaid expenses
of $257,000, $209,000 and
$14,000 respectively, offset
in part by an increase
in cash and cash equivalents
of approximately $317,000.
Accounts
receivable decreased due primarily to a lower sales volume during the
current
quarter.
The
increase in cash
and
cash equivalents
was due primarily to
the issuance of convertible
promissory notes in December 2011
.
Working capital as of June 30, 2012 amounted to $1,923,219. This compares to $2,179,908 a year earlier. Current assets were 3.1 times current liabilities compared to 3.8 a year ago. The quick ratio was 1.1 compared to 1.0 a year ago.
Internally generated funds during the nine months ended June 30, 2012 were a negative $92,247. The primary reason for the negative cash flow from operations was the net loss during the period. The Company anticipates capital expenditures of approximately $50,000 during fiscal 2012 primarily for equipment and tools required to fulfill an anticipated large order for an OEM . The Company believes that cash and cash equivalents together with available short-term financing will provide adequate funding of the Company's working capital needs through the end of fiscal 2012.
Shareholders' equity during the nine months ended June 30, 2012 decreased by $334,146 which was the net loss during the period of $578,896, the issue cost of Convertible Promissory Notes of $34,235, the sale of Class A Conversion shares of $233,438, the sale of Class B Common Shares of $37,000 and $8,547 of share-based compensation expense.
During fiscal 2012 the Company's business may require a short-term increase in inventory and accounts receivables. Whenever there may be a requirement to increase inventory in fiscal 2012 there will be a negative but temporary impact on liquidity. The Company has reduced headcount, product development, and marketing, administrative and sales related expenses in order to appropriately manage its working capital. The Company believes that internally generated funds and available short-term financing will provide sufficient liquidity to meet ongoing working capital requirements.Critical Accounting Policies
Forward-Looking Statements
Market Risk
The Company is exposed to certain market risks from transactions that are entered into during the normal course of business. The Company has not entered into derivative financial instruments for trading purposes. The Company's primary market risk is exposure related to interest rate risk. The Company's only debt subject to interest rate risk is its revolving credit facility, which is subject to a variable rate of interest based on the prime commercial rate. The current outstanding balance on this credit facility is $0. As a result, the Company believes that the market risk relating to interest rate movements is minimal.
The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market. There has been no material developments in this legal proceeding since the filing of Form 10-K for fiscal 2011. Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of the patent infringement matter will have on the Company's results of operations, financial position or cash flows.
The Company is a named defendant along with numerous other companies in a suit in the State of New York r egarding asbestos harm to the plaintiff. The Company has been informed by the plaintiff's attorney that we will be dismissed from the suit.
The Company is a named defendant along with numerous other companies in a suit in the State of Michigan regarding asbestos harm to the plaintiff. We have engaged a Michigan attorney to provide representation for us. The Company believes the suit is without merit and expects it will be able to obtain a dismissal for similar reasons a dismissal is imminent in the New York action.
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
11
|
|
Statement Regarding Computation of Earnings Per share and
Common Share Equivalents
|
|
|
|
|
|
31.1
|
|
Rule 13a-14(a)/15d-14(a) Certification by the Chief Executive Officer |
|
|
|
|
|
31.2
|
|
Rule 13a-14(a)/15d-14(a) Certification by the Chief Financial Officer |
|
|
|
|
|
32.1
|
|
Certification by the
Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
32.2
|
|
Certification by the
Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
101.INS**
|
|
XBRL Instance
|
|
|
|
|
|
101.SCH**
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
101.CAL**
|
|
XBRL Taxonomy Extension Calculation
|
|
|
|
|
|
101.DEF**
|
|
XBRL Taxonomy Extension Definition
|
|
|
|
|
|
101.LAB**
|
|
XBRL Taxonomy Extension Labels
|
|
|
|
|
|
101.PRE**
|
|
XBRL Taxonomy Extension Presentation
|
|
|
|
|
** XBRL information is
furnished and not filed or a part of a registration statement or
prospectus for purposes of sections 11 or 12 of the Securities Act of
1933, as amended, is deemed not filed for purposes of section 18 of the
Securities Exchange Act of 1934, as amended, and otherwise is not
subject to liability under these sections.
Pursuant
to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on
its
behalf by the undersigned thereunto duly authorized.
|
|
(Registrant) |
|
|
|
||
|
|
||
|
|
||
|
Date: August 13,
2012
|
/s/ R. L. Bauman | |
|
|
R. L. Bauman,
Chief Executive Officer,
President, and Treasurer |
|
|
|
|
|
|
|
|
|
|
Date: August 13,
2012
|
/s/ G. M. Zoloty | |
|
|
G. M. Zoloty, Chief Financial Officer | |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|